Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

N-acetylcysteine may help treat uterine and placental issues in PCOS.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.

The guideline provides recommendations for managing alopecia areata effectively.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Different parts of the body have unique immune characteristics in their skin.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

People with skin diseases often face bullying, and global efforts are needed to stop it.